SEC Form 4 · accession 0001225208-26-007499
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Bourla
Officer — Chairman & CEO · Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 1, 2026 · 5:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000078003
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock Units SSPF1,F2 | — | Aug 31, 2026 | A | 21 | A | — | — | Common Stock | 21 | 784,012 | D |
Explanation of responses
- F1Each unit represents one phantom share of common stock.
- F2These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.